Physician profile
David Bendorf
NPI 1639107881
$20,620.91
in general payments reported to CMS, 2019-2025
45 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,263 · 2020: $415 · 2021: $608 · 2022: $241 · 2023: $13K · 2024: $5,158 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $11K · Travel and Lodging: $6,024 · Food and Beverage: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $11,020.00 |
| Travel and Lodging | $6,023.97 |
| Food and Beverage | $1,049.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,012.61 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Nuvasive, INC. | $2,344.22 | 2023 | Alif |
| Novo Nordisk INC | $248.33 | 2019-2022 | |
| Amgen INC. | $149.53 | 2019-2021 | |
| Davol INC. | $143.98 | 2024-2025 | Phasix Mesh |
| Janssen Pharmaceuticals, INC | $137.03 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.90 | 2021-2025 | |
| Csl Behring | $106.69 | 2023 | Kcentra |
| Pfizer INC. | $97.43 | 2019-2022 | |
| Abbvie INC. | $91.20 | 2023-2024 | Dalvance, Natrelle Saline-Filled Breast Implants |
| Biohaven Pharmaceuticals, INC. | $89.09 | 2021 | |
| Genentech USA, INC. | $70.38 | 2019-2020 | |
| Tela Bio, INC. | $68.66 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Vertex Pharmaceuticals Incorporated | $67.26 | 2024-2025 | |
| Acera Surgical, INC. | $64.52 | 2022-2023 | Restrata Wound Matrix |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bendorf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.